Although several IDUA mutations have been confirmed from clinical symptoms [9], most remain to be elucidated for causing MPS I. Thus, apart from the conventional diagnostic approaches, this calls for the development of a fast, but effective, in vivo platform that can preliminarily assess which mutated nucleotides of IDUA might be tightly correlated with the occurrence of MPS I. Here, IDUA is linked to Scheie syndrome.